Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
about
The interplay between the microbiome and the adaptive immune response in cancer developmentThe role and regulation of human Th17 cells in tumor immunityPreclinical validation of interleukin 6 as a therapeutic target in multiple myelomaElevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myelomaHuman dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responsesAdvances in the understanding of myeloma bone disease and tumour growth.Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environmentBone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.Cytokine-mediated bone destruction in rheumatoid arthritis.FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.DNA methylation in multiple myeloma is weakly associated with gene transcription.TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis.Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses.Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Bone-immune cell crosstalk: bone diseases.The immune microenvironment of myelomaSurvivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.T(H)17 cells in tumour immunity and immunotherapy.The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapies.Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma.Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance.Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.The role of Interleukin-17A and Interleukin-17E in multiple myeloma patientsCellular mechanisms of multiple myeloma bone diseaseThe Interplay between the bone and the immune systemSpontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.Th17 and Treg cells in bone related diseases.Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.Interleukin-23/Th17 pathways and inflammatory bowel disease.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.Effect of IL-17 in the development of colon cancer in miceChemokines and chemokine receptors in multiple sclerosis.Tumor-host cell interactions in the bone disease of myeloma.Drug-mediated and cellular immunotherapy in multiple myeloma.The bone marrow stroma in hematological neoplasms--a guilty bystander.The role of regulatory T cells and TH17 cells in multiple myeloma.Immunologic microenvironment and personalized treatment in multiple myeloma.Fact or fiction--identifying the elusive multiple myeloma stem cell.Staging and prognostication of multiple myeloma
P2860
Q26745703-27550338-72CA-4BF3-8129-65071E09EC85Q27011396-B38CB3AD-B301-4B9E-A384-765B95385250Q27027729-55B06C97-81AF-4A1B-9C8E-6316B8ABAB07Q30431530-C0605519-0E54-47C6-846D-A51D6AB9AFC9Q33728341-A6B81629-4232-45F2-8B22-E5E62D7C1565Q33829022-92A56422-5039-4431-B698-32C4074C4002Q33840997-9B1530F7-24A4-43F2-A31F-15E289897118Q34093086-47693EF5-ACDE-484A-9031-2B984BE94815Q34155848-FE08E725-C5EE-440A-B7A1-4A6430F40CA9Q34252489-C102FDCD-EFDC-45E1-84EE-31F1C83B754FQ34402407-3E88AC57-E608-4628-804E-5F765C0EEBB5Q34534256-41861421-67C9-4D7D-B089-83E72656E1A7Q34570319-24805493-A913-4791-8770-0161CABD2ABDQ34785104-E566770B-7BDC-4C96-A094-1D07256E9D6FQ35584599-D220A462-E5D3-4E6C-B9B9-405F0ECD64D5Q35592362-C044B040-3D6B-4769-8C66-BAA03D0D2892Q35603152-AA0ABB77-59DF-491A-B007-66C8CD853B0FQ35623772-E20FB191-499C-4B9E-891B-44DEA4209F31Q35623903-9950C02E-062C-45F3-9C80-68F70F84B8E7Q35669068-9B50313C-105E-4305-9ECB-F5839C55F3ABQ35849249-91BD6F20-FF70-448A-A261-68C68DCAE9F5Q35944713-F97667C1-730F-4AE6-98CB-35A03976928AQ36542800-DD6AF82D-404B-4E35-B351-3E792182D944Q36577172-4D7A2FE3-EA5F-4BC7-ADA8-A3DDC8687213Q36925346-0EC2CA2C-6306-4915-BE33-5FAC939D3FD1Q37052226-8D3289D4-82F6-4A72-A3ED-CB976FA8097FQ37233276-6DC9FA04-A935-45A7-9B69-0FECA7277548Q37239790-93DC21A0-7728-44C5-AEDA-BDA6C74D4CF0Q37396070-12299709-A2F7-4902-9F39-BED75B367201Q37404716-631DD437-68C5-4C22-A22E-C08A4DBABE88Q37517482-006B15AD-3766-412D-906C-9E36BD53EC45Q37581683-383FA8C5-AF97-4CF7-86D9-9CA8510D62C7Q37594837-8ED09AD5-E7B6-46BA-8FFF-49ED0EC2CCCDQ37771082-3CDD2E8A-8B31-4E09-B528-670B403930C0Q37773257-BA9CEA89-100F-4839-95C3-E2EB6127A173Q37859253-DBEB14CE-92A4-4731-99AD-E84079917F9FQ38001433-637F2B76-276E-4F7A-A262-CC2A8C02EB61Q38108390-0C5DAD72-047F-4A27-948E-9963433268C6Q38169258-825D1329-2BCE-40D9-AD6B-E0640346E887Q38183871-1D239671-A0FB-4039-87CE-B8096BC52283
P2860
Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dendritic cells mediate the in ...... arrow of patients with myeloma
@en
type
label
Dendritic cells mediate the in ...... arrow of patients with myeloma
@en
prefLabel
Dendritic cells mediate the in ...... arrow of patients with myeloma
@en
P2093
P2860
P1433
P1476
Dendritic cells mediate the in ...... arrow of patients with myeloma
@en
P2093
Amitabha Mazumder
Anjli Kukreja
David Vesole
Kavita M Dhodapkar
Madhav V Dhodapkar
Phillip Matthews
Scott Barbuto
Sundar Jagannath
P2860
P304
P356
10.1182/BLOOD-2008-03-143222
P407
P577
2008-07-30T00:00:00Z